Last $1.59 USD
Change Today -0.08 / -4.79%
Volume 27.7K
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark A. Emalfarb

Founder, Chairman, Chief Executive Officer, President and Chairman of Nominating Committee, Dyadic International, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 1 different industries.

See Board Relationships
59--

Background*

Mr. Mark A. Emalfarb Co-Founded Dyadic International Inc., in 1979 and has been its Chairman and Chief Executive Officer since June 2008. Mr. Emalfarb has been the President of Dyadic International Inc., since October 29, 2004. He served as the Chairman and Chief Executive Officer of the Dyadic International Inc., from October 29, 2004 to September 24, 2007. Mr. Emalfarb served as the President, Secretary and Treasurer of Dyadic International Inc., since October 29, ...

Read Full Background

Corporate Headquarters*

140 Intracoastal Pointe Drive
Jupiter, Florida 33477

United States

Phone: 561-743-8333
Fax: 561-743-8343

Board Members Memberships*

Founder, Chairman, Chief Executive Officer, President and Chairman of Nominating Committee

Education*

BA
University of Iowa

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DYAI:US $1.59 USD -0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Feike Sijbesma Chairman of Managing Board, Chief Executive Officer and Chairman of DSM Nutritional Products
Koninklijke DSM N.V.
€1.4M
Karl-Ludwig Kley Chairman of Executive Board
Merck KGaA
€5.4M
Richard Ridinger Chief Executive Officer
Lonza Group Ltd
--
Peder Holk Nielsen Chief Executive Officer and President
Novozymes A/S
kr8.3M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYADIC INTERNATIONAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.